UK markets close in 3 hours 50 minutes

Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
32.58+0.16 (+0.49%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 10.45B
Enterprise value 8.14B
Trailing P/E 12.89
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.56
Price/book (mrq)2.86
Enterprise value/revenue 2.78
Enterprise value/EBITDA 8.85

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-29.05%
S&P500 52-week change 323.20%
52-week high 348.31
52-week low 326.95
50-day moving average 336.70
200-day moving average 336.44

Share statistics

Avg vol (3-month) 33.9M
Avg vol (10-day) 32.8M
Shares outstanding 5322.32M
Implied shares outstanding 6324.75M
Float 8122.89M
% held by insiders 162.11%
% held by institutions 14.84%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.66
Forward annual dividend yield 45.13%
Trailing annual dividend rate 31.49
Trailing annual dividend yield 34.60%
5-year average dividend yield 41.58
Payout ratio 459.57%
Dividend date 3N/A
Ex-dividend date 430 Apr 2024
Last split factor 21.3:1
Last split date 330 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 27.65%
Operating margin (ttm)45.90%

Management effectiveness

Return on assets (ttm)13.38%
Return on equity (ttm)23.24%

Income statement

Revenue (ttm)2.93B
Revenue per share (ttm)9.10
Quarterly revenue growth (yoy)-22.40%
Gross profit (ttm)N/A
EBITDA 1.11B
Net income avi to common (ttm)810.63M
Diluted EPS (ttm)2.52
Quarterly earnings growth (yoy)3.20%

Balance sheet

Total cash (mrq)3.08B
Total cash per share (mrq)9.55
Total debt (mrq)764.68M
Total debt/equity (mrq)20.71%
Current ratio (mrq)2.87
Book value per share (mrq)11.35

Cash flow statement

Operating cash flow (ttm)1.12B
Levered free cash flow (ttm)627.84M